Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Oxytocin Buffers Stress Response in Individuals With Impaired Coping Abilities

This study has been completed.
Sponsor:
Information provided by:
University of Osnabrueck
ClinicalTrials.gov Identifier:
NCT01065610
First received: February 8, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
  Purpose

This study investigated, if people with impaired coping abilities benefit from intranasal oxytocin application.


Condition Intervention
Coping Skills
Oxytocin
Stress
Drug: Oxytocin
Drug: Placebo

Study Type: Interventional
Official Title: Oxytocin Buffers Cortisol Responses to Stress in Individuals With Impaired Coping Abilities

Resource links provided by NLM:


Further study details as provided by University of Osnabrueck:

Primary Outcome Measures:
  • Salivary Cortisol

Study Start Date: January 2008
Study Completion Date: October 2008
Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Oxytocin
Intranasal Oxytocin, 24 IU
Drug: Oxytocin
Placebo Comparator: Placebo Drug: Placebo

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • male

Exclusion Criteria:

  • psychological disorders
  • drug abuse
  • cigarette smoking
  • coronary diseases
  • nervous system diseases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01065610     History of Changes
Other Study ID Numbers: Neurolab_RD_001
Study First Received: February 8, 2010
Last Updated: February 8, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Oxytocin
Oxytocics
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on November 20, 2014